Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Eva Baigorri"'
Autor:
Jitra Kriangkum, Sarah N Motz, Tanner Mack, Sara Beiggi, Eva Baigorri, Hemalatha Kuppusamy, Andrew R Belch, James B Johnston, Linda M Pilarski
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0137232 (2015)
The immunoglobulin heavy chain (IGH) gene rearrangement in chronic lymphocytic leukemia (CLL) provides a unique molecular signature; however, we demonstrate that 26/198 CLL patients (13%) had more than one IGH rearrangement, indicating the power of m
Externí odkaz:
https://doaj.org/article/7f4617d9519e44029a8c3809cf2e4678
Autor:
Hemalatha Kuppusamy, Helga M Ogmundsdottir, Eva Baigorri, Amanda Warkentin, Hlif Steingrimsdottir, Vilhelmina Haraldsdottir, Michael J Mant, John Mackey, James B Johnston, Sophia Adamia, Andrew R Belch, Linda M Pilarski
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e100691 (2014)
Genetic variations in the hyaluronan synthase 1 gene (HAS1) influence HAS1 aberrant splicing. HAS1 is aberrantly spliced in malignant cells from multiple myeloma (MM) and Waldenstrom macroglobulinemia (WM), but not in their counterparts from healthy
Externí odkaz:
https://doaj.org/article/3b3843e51fba436ebe244549f552ce0a
Autor:
Linda M. Pilarski, Eva Baigorri, Michael J. Mant, Patrick M. Pilarski, Penelope Adamson, Heddy Zola, Andrew R. Belch
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 2 (2008)
Potential progenitor B cell compartments in multiple myeloma (MM) are clinically important. MM B cells and some circulating MM plasma cells express CD20, predicting their clearance by treatment with anti-CD20. Here we describe two types of clonotypic
Externí odkaz:
https://doaj.org/article/40b9e3acdacd4dc9b94e25640b494818
Autor:
Sara Beiggi, James B. Johnston, Tanner Mack, Linda M. Pilarski, Jitra Kriangkum, Hemalatha Kuppusamy, Sarah N. Motz, Eva Baigorri, Andrew Belch
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0137232 (2015)
PLoS ONE
PLoS ONE
The immunoglobulin heavy chain (IGH) gene rearrangement in chronic lymphocytic leukemia (CLL) provides a unique molecular signature; however, we demonstrate that 26/198 CLL patients (13%) had more than one IGH rearrangement, indicating the power of m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2efd782c166dd246b878343b81024ec
http://europepmc.org/articles/PMC4564241?pdf=render
http://europepmc.org/articles/PMC4564241?pdf=render
Autor:
Andrew Belch, Hlif Steingrimsdottir, James B. Johnston, John R. Mackey, Linda M. Pilarski, Sophia Adamia, Eva Baigorri, Michael J. Mant, Vilhelmína Haraldsdóttir, Helga M. Ögmundsdóttir, Hemalatha Kuppusamy, Amanda Warkentin
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 6, p e100691 (2014)
PLoS ONE, Vol 9, Iss 6, p e100691 (2014)
Genetic variations in the hyaluronan synthase 1 gene (HAS1) influence HAS1 aberrant splicing. HAS1 is aberrantly spliced in malignant cells from multiple myeloma (MM) and Waldenstrom macroglobulinemia (WM), but not in their counterparts from healthy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff456921fb1b07db33d4d24c58c158b6
http://europepmc.org/articles/PMC4065063
http://europepmc.org/articles/PMC4065063
Autor:
Christopher P. Venner, Irwindeep Sandhu, Joanne D. Hewitt, Andrew Belch, Linda M. Pilarski, Michael P. Chu, Eva Baigorri, Jitra Kriangkum
Publikováno v:
Blood. 128:2113-2113
Background Multiple myeloma (MM) remains incurable despite treatment advances. While passive immunotherapy such as anti-CD38 antibodies is highly effective, active immunotherapy may provide long-lasting remissions by virtue of triggering memory. A ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3287dad7108e196c3255388e967ae45b
https://doi.org/10.1182/blood.v128.22.2113.2113
https://doi.org/10.1182/blood.v128.22.2113.2113
Autor:
Michael J. Mant, Patrick M. Pilarski, Linda M. Pilarski, Eva Baigorri, Penelope J. Adamson, Andrew R. Belch, Heddy Zola
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 2 (2008)
Clinical Medicine. Oncology
Clinical Medicine. Oncology
Potential progenitor B cell compartments in multiple myeloma (MM) are clinically important. MM B cells and some circulating MM plasma cells express CD20, predicting their clearance by treatment with anti-CD20. Here we describe two types of clonotypic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ad4e4777d0c99cc25367622165c7965
https://doi.org/10.4137/cmo.s615
https://doi.org/10.4137/cmo.s615
Publikováno v:
Blood. 108:5037-5037
In this study we describe stably transfected cells expressing RHAMM, the receptor for hyaluronan (HA) mediated motility, under the control of a tetracycline-inducible promoter. We created this model system to determine the potential for RHAMM to prom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0093f6813c2ca5c84630767fd8699c74
https://doi.org/10.1182/blood.v108.11.5037.5037
https://doi.org/10.1182/blood.v108.11.5037.5037